Abstract
Retinal glial (Müller) cells may play a major role in vascular eye diseases as they secrete vascular endothelial growth factor (VEGF), a hypoxia-induced angiogenic cytokine. They also release significant amounts of the anti-angiogenic factors, transforming growth factor (TGF)-beta2, pigment epithelium derived factor (PEDF), and thrombospondin-1 (TSP-1). Exposure of human (MIO-M1) and guinea-pig Müller cells to hypoxia resulted in a decreased release of TGF-beta2 and PEDF but in an elevated secretion of TSP-1. When retinal endothelial cells were exposed to VEGF/anti-angiogenic factor ratios mimicking those found in culture media of Müller cells under normoxia or hypoxia, their proliferation was significantly inhibited by TGF-beta2, PEDF or TSP-1. Thus Müller cells may provide a permanent anti-proliferative condition for retinal endothelial cells.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Analysis of Variance
-
Animals
-
Animals, Newborn
-
Cell Division / physiology
-
Cell Hypoxia
-
Cells, Cultured
-
Cytokines / metabolism
-
Dose-Response Relationship, Drug
-
Drug Interactions
-
Endothelial Cells / metabolism
-
Enzyme-Linked Immunosorbent Assay / methods
-
Eye Proteins*
-
Guinea Pigs
-
Humans
-
Nerve Growth Factors*
-
Neuroglia / metabolism*
-
Proteins / metabolism*
-
Proteins / pharmacology
-
Retina / cytology*
-
Serpins / metabolism*
-
Serpins / pharmacology
-
Thrombospondin 1 / metabolism*
-
Thrombospondin 1 / pharmacology
-
Transforming Growth Factor beta / metabolism*
-
Transforming Growth Factor beta / pharmacology
-
Transforming Growth Factor beta2
-
Vascular Endothelial Growth Factor A / metabolism*
-
Vascular Endothelial Growth Factor A / pharmacology
Substances
-
Cytokines
-
Eye Proteins
-
Nerve Growth Factors
-
Proteins
-
Serpins
-
TGFB2 protein, human
-
Thrombospondin 1
-
Transforming Growth Factor beta
-
Transforming Growth Factor beta2
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
pigment epithelium-derived factor